XTX Topco’s Cocrystal Pharma COCP Stock Holding History

XTX Topco’s Portfolio COCP Stock Details COCP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$36.4K	Buy	36,031 +20,890	+138%	+$21.6K	﹤0.01%	3410
2025 Q4	$14.8K	Buy	+15,141	New	+$16K	﹤0.01%	3123

Other funds holding COCP

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T3 Companies New York $76.8M AUM

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

XTX Topco's COCP Position: Q1 2026 in Review

XTX Topco increased its Cocrystal Pharma (COCP) stake by 138% in Q1 2026, buying an estimated $21.6K and bringing the position to 36,031 shares worth $36.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3410.

XTX Topco first reported a position in COCP in Q4 2025 and has held it in 2 quarters since. 26 funds tracked by Wall St. Rank hold COCP as of Q1 2026.

XTX Topco held 36,031 shares of Cocrystal Pharma worth $36.4K as of Q1 2026.
XTX Topco bought 20,890 Cocrystal Pharma shares in Q1 2026, an estimated $21.6K.
Cocrystal Pharma made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3410 holding.
XTX Topco first reported a position in Cocrystal Pharma in Q4 2025 and has held it in 2 quarters since.
26 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.